BB
Blake Borgeson (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales, 1 filed past the two-business-day deadline), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $961K of RXRX (220,000 sh × $4.37, as filed), executed Dec 2 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.3M
shares × price, as filed
Last traded
Nov 3
Filed Nov 4
Median ADV $67.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
RXRXRecent filings
RXRXSALE
Recursion Pharmaceuticals, Inc.
View filing →
$959K220,000 sh × $4.36
Exec Jan 6
Filed Jan 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $961K
220,000 sh × $4.37
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET